Five-year prospective outcomes of medical management and microvascular decompression in trigeminal neuralgia
Open Access
- 16 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (10) , 1-11
Abstract
Background: Trigeminal neuralgia is a severe facial pain disorder with major impact on quality of life. Long-term prospective data comparing medical and surgical treatments remain scarce. This study compared 5-year outcomes of medical management and microvascular decompression (MVD) and explored predictors of treatment response. Methods: We conducted a prospective observational cohort study at a national referral center (2012–2019). Consecutive patients with classical or idiopathic trigeminal neuralgia underwent MRI, baseline assessment, and systematic 5-year follow-up. Treatment allocation (medical therapy or MVD) followed clinical evaluation and international guidelines. The primary outcome was categorized as pain-free without medication, pain-free with medication, continued pain without medication, or continued pain with medication. Results: Of 626 eligible patients, 227 completed follow-up (95 MVD, 132 medical). Pain-free without medication was achieved in 59% of MVD patients versus 19% of medically treated [relative risk (RR) 3.03, 95% confidence interval (CI) 1.67–5.50]. Pain-free with medication occurred in 1% after MVD versus 14% of the medical cohort (RR 0.16, 95% CI 0.04–0.69). Continued pain on medication was less frequent after MVD (22% vs 49%; RR 0.44, 95% CI 0.24–0.80). Male sex predicted excellent outcome after MVD (odds ratio 2.60, 95% CI 1.02–6.91). Postoperative hypoesthesia occurred in 23% and hearing impairment in 7%, while 55% of medically treated patients reported side effects. Conclusions: MVD provided superior long-term pain relief, higher rates of medication-free pain freedom, and reduced medication use compared with medical management, supporting earlier surgical consideration in selected patients and emphasizing individualized, guideline-based care.Keywords
Funding Information
- Trigeminus Foreningen
- National Hospital
This publication has 55 references indexed in Scilit:
- How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?Archives of Disease in Childhood, 2008
- Patient Burden of Trigeminal Neuralgia: Results from a Cross‐Sectional Survey of Health State Impairment and Treatment Patterns in Six European CountriesPain Practice, 2006
- The international classification of headache disorders. 2nd edition (ICHD-II)Revue Neurologique, 2005
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendationsPain, 2005
- Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgiaPain, 2002
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001
- Microvascular decompression of cranial nerves: lessons learned after 4400 operationsJournal of Neurosurgery, 1999
- The Long-Term Outcome of Microvascular Decompression for Trigeminal NeuralgiaNew England Journal of Medicine, 1996
- Facial Nerve Grading SystemOtolaryngology–Head and Neck Surgery, 1985
- Long-term treatment of trigeminal neuralgia with carbamazepinePostgraduate Medical Journal, 1981